For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Compugen Ltd (NASDAQ: CGEN) closed at $1.68 down -7.18% from its previous closing price of $1.81. In other words, the price has decreased by -$7.18 from its previous closing price. On the day, 0.67 million shares were traded.
Ratios:
For a deeper understanding of Compugen Ltd’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.14 and its Current Ratio is at 4.14. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on January 13, 2025, initiated with a Outperform rating and assigned the stock a target price of $4.
On August 05, 2022, Jefferies Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $2.
Valuation Measures:
As of this moment, Compugen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 87.50. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.60. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.51 while its Price-to-Book (P/B) ratio in mrq is 2.49.
Stock Price History:
Over the past 52 weeks, CGEN has reached a high of $3.03, while it has fallen to a 52-week low of $1.35. The 50-Day Moving Average of the stock is -16.48%, while the 200-Day Moving Average is calculated to be -9.52%.
Shares Statistics:
A total of 89.54M shares are outstanding, with a floating share count of 87.64M. Insiders hold about 2.12% of the company’s shares, while institutions hold 14.81% stake in the company.
Earnings Estimates
As of right now, 2.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.06 and low estimates of -$0.06.
Analysts are recommending an EPS of between -$0.23 and -$0.28 for the fiscal current year, implying an average EPS of -$0.25. EPS for the following year is -$0.22, with 1.0 analysts recommending between -$0.22 and -$0.22.
Revenue Estimates
A total of 1 analysts believe the company’s revenue will be $5M this quarter.It ranges from a high estimate of $5M to a low estimate of $5M. As of the current estimate, Compugen Ltd’s year-ago sales were $2.56MFor the next quarter, 1 analysts are estimating revenue of $5M. There is a high estimate of $5M for the next quarter, whereas the lowest estimate is $5M.
A total of 2 analysts have provided revenue estimates for CGEN’s current fiscal year. The highest revenue estimate was $62M, while the lowest revenue estimate was $20M, resulting in an average revenue estimate of $41M. In the same quarter a year ago, actual revenue was $27.86MBased on 3 analysts’ estimates, the company’s revenue will be $39.21M in the next fiscal year. The high estimate is $49.63M and the low estimate is $22M.
